New Delhi: Amid rising pressure to allow exports of an anti-malarial drug being tested on patients infected with coronavirus, the government is likely to take a decision tomorrow and clear the move after calculating sufficient stocks for the country, sources have told NDTV. Last month, India had banned the export of hydroxychloroquine and formulations of the malaria drug while experts test its efficacy in helping treat COVID-19 patients. There are currently no approved treatments, or preventive vaccines for COVID-19, the highly contagious, sometimes deadly respiratory illness caused by coronavirus. Hydroxychloroquine, a malaria drug, is among the medications undergoing testing as...